AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS
· Delayed Price · Currency is USD
0.0020
0.00 (0.00%)
Jan 21, 2025, 4:00 PM EST
AXIM Biotechnologies Revenue
AXIM Biotechnologies had revenue of $17.48K in the quarter ending June 30, 2024, with 76.04% growth. This brings the company's revenue in the last twelve months to $92.90K, up 257.95% year-over-year. In the year 2023, AXIM Biotechnologies had annual revenue of $39.52K with 345.27% growth.
Revenue (ttm)
92.90K
Revenue Growth
+257.95%
P/S Ratio
6.59
Revenue / Employee
13.27K
Employees
7
Market Cap
750.95K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
AXIM Biotechnologies News
- 10 months ago - VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024 - GlobeNewsWire
- 1 year ago - AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation - GlobeNewsWire
- 1 year ago - AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production - GlobeNewsWire
- 1 year ago - AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease - Business Wire
- 1 year ago - AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test - Business Wire
- 1 year ago - Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 1 year ago - AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide - GlobeNewsWire
- 1 year ago - AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch - GlobeNewsWire